Amalgamated Bank’s Ionis Pharmaceuticals IONS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $913K | Sell |
11,519
-535
| -4% | -$40.3K | 0.01% | 1145 |
|
|
2026
Q1 | $905K | Sell |
12,054
-401
| -3% | -$31.6K | 0.01% | 1104 |
|
|
2025
Q4 | $985K | Buy |
12,455
+260
| +2% | +$19.6K | 0.01% | 1065 |
|
|
2025
Q3 | $798K | Buy |
12,195
+669
| +6% | +$32.7K | 0.01% | 1142 |
|
|
2025
Q2 | $455K | Buy |
11,526
+953
| +9% | +$31.2K | ﹤0.01% | 1307 |
|
|
2025
Q1 | $319K | Buy |
10,573
+281
| +3% | +$9.2K | ﹤0.01% | 1409 |
|
|
2024
Q4 | $360K | Buy |
10,292
+335
| +3% | +$12.5K | ﹤0.01% | 1412 |
|
|
2024
Q3 | $399K | Buy |
9,957
+300
| +3% | +$14K | ﹤0.01% | 1384 |
|
|
2024
Q2 | $460K | Buy |
9,657
+454
| +5% | +$18.6K | ﹤0.01% | 1327 |
|
|
2024
Q1 | $399K | Sell |
9,203
-19,792
| -68% | -$943K | ﹤0.01% | 1397 |
|
|
2023
Q4 | $1.47M | Sell |
28,995
-91
| -0.3% | -$4.36K | 0.01% | 1011 |
|
|
2023
Q3 | $1.32M | Sell |
29,086
-373
| -1% | -$15.4K | 0.01% | 1020 |
|
|
2023
Q2 | $1.21M | Buy |
29,459
+351
| +1% | +$13.5K | 0.01% | 1053 |
|
|
2023
Q1 | $1.04M | Sell |
29,108
-2,987
| -9% | -$112K | 0.01% | 1108 |
|
|
2022
Q4 | $1.21M | Buy |
32,095
+503
| +2% | +$21.2K | 0.01% | 1072 |
|
|
2022
Q3 | $1.4M | Sell |
31,592
-1,731
| -5% | -$72.9K | 0.01% | 975 |
|
|
2022
Q2 | $1.23M | Buy |
33,323
+1,389
| +4% | +$52.4K | 0.01% | 1075 |
|
|
2022
Q1 | $1.18M | Buy |
31,934
+2,610
| +9% | +$85.4K | 0.01% | 1130 |
|
|
2021
Q4 | $892K | Buy |
29,324
+3,923
| +15% | +$123K | 0.01% | 1298 |
|
|
2021
Q3 | $852K | Sell |
25,401
-1,532
| -6% | -$57.7K | 0.01% | 1324 |
|
|
2021
Q2 | $1.07M | Buy |
26,933
+7,267
| +37% | +$285K | 0.01% | 1252 |
|
|
2021
Q1 | $884K | Sell |
19,666
-1,586
| -7% | -$88.5K | 0.03% | 645 |
|
|
2020
Q4 | $1.2M | Sell |
21,252
-28
| -0.1% | -$1.4K | 0.05% | 430 |
|
|
2020
Q3 | $1.01M | Sell |
21,280
-319
| -1% | -$17.7K | 0.04% | 441 |
|
|
2020
Q2 | $1.27M | Sell |
21,599
-12,106
| -36% | -$673K | 0.06% | 316 |
|
|
2020
Q1 | $1.59M | Sell |
33,705
-931
| -3% | -$51.9K | 0.04% | 436 |
|
|
2019
Q4 | $2.09M | Buy |
34,636
+2,149
| +7% | +$128K | 0.04% | 490 |
|
|
2019
Q3 | $1.95M | Buy |
32,487
+4,195
| +15% | +$273K | 0.04% | 449 |
|
|
2019
Q2 | $1.82M | Sell |
28,292
-108
| -0.4% | -$7.63K | 0.04% | 454 |
|
|
2019
Q1 | $2.31M | Buy |
28,400
+521
| +2% | +$33.6K | 0.06% | 326 |
|
|
2018
Q4 | $1.51M | Buy |
27,879
+10,762
| +63% | +$549K | 0.04% | 447 |
|
|
2018
Q3 | $883K | Sell |
17,117
-12,049
| -41% | -$566K | 0.02% | 738 |
|
|
2018
Q2 | $1.22M | Buy |
29,166
+2,762
| +10% | +$122K | 0.03% | 663 |
|
|
2018
Q1 | $1.16M | Buy |
26,404
+1,702
| +7% | +$86.5K | 0.03% | 634 |
|
|
2017
Q4 | $1.24M | Buy |
24,702
+1,350
| +6% | +$74K | 0.03% | 603 |
|
|
2017
Q3 | $1.18M | Buy |
23,352
+161
| +0.7% | +$8.43K | 0.04% | 558 |
|
|
2017
Q2 | $1.18M | Buy |
23,191
+5,612
| +32% | +$261K | 0.04% | 547 |
|
|
2017
Q1 | $707K | Sell |
17,579
-3,880
| -18% | -$174K | 0.04% | 636 |
|
|
2016
Q4 | $1.03M | Buy |
21,459
+2,225
| +12% | +$88K | 0.05% | 459 |
|
|
2016
Q3 | $705K | Buy |
19,234
+2
| +0% | +$63 | 0.04% | 547 |
|
|
2016
Q2 | $690K | Buy |
19,232
+5,071
| +36% | +$164K | 0.04% | 566 |
|
|
2016
Q1 | $574K | Buy |
14,161
+1,108
| +8% | +$45K | 0.06% | 458 |
|
|
2015
Q4 | $808K | Sell |
13,053
-945
| -7% | -$51K | 0.1% | 207 |
|
|
2015
Q3 | $566K | Buy |
13,998
+210
| +2% | +$10.9K | 0.06% | 434 |
|
|
2015
Q2 | $793K | Buy |
13,788
+1,844
| +15% | +$117K | 0.08% | 289 |
|
|
2015
Q1 | $760K | Buy |
11,944
+461
| +4% | +$31.3K | 0.09% | 260 |
|
|
2014
Q4 | $709K | Buy |
11,483
+16
| +0.1% | +$790 | 0.11% | 214 |
|
|
2014
Q3 | $445K | Sell |
11,467
-5
| -0% | -$177 | 0.07% | 391 |
|
|
2014
Q2 | $395K | Sell |
11,472
-68
| -0.6% | -$2.14K | 0.06% | 463 |
|
|
2014
Q1 | $499K | Sell |
11,540
-105
| -0.9% | -$5.09K | 0.09% | 318 |
|
|
2013
Q4 | $464K | Buy |
+11,645
| New | +$415K | 0.08% | 339 |
|
Other funds holding IONS
TBC
TCM
PA
Amalgamated Bank's IONS Position: Q2 2026 in Review
Amalgamated Bank reduced its Ionis Pharmaceuticals (IONS) stake by 4.4% in Q2 2026, selling an estimated $40.3K and leaving 11,519 shares worth $913K. The position accounts for 0.01% of the portfolio, ranked #1145.
Amalgamated Bank first reported a position in IONS in Q4 2013 and has held it in 51 quarters since. The position peaked at $2.31M in Q1 2019. 240 funds tracked by Wall St. Rank hold IONS as of Q2 2026.
- Amalgamated Bank held 11,519 shares of Ionis Pharmaceuticals worth $913K as of Q2 2026.
- Amalgamated Bank sold 535 Ionis Pharmaceuticals shares in Q2 2026, an estimated $40.3K.
- Ionis Pharmaceuticals made up 0.01% of Amalgamated Bank's portfolio in Q2 2026, its #1145 holding.
- Amalgamated Bank first reported a position in Ionis Pharmaceuticals in Q4 2013 and has held it in 51 quarters since.
- Amalgamated Bank's Ionis Pharmaceuticals position peaked at $2.31M in Q1 2019.
- 240 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2026.
Based on Amalgamated Bank's 13F filing for Q2 2026, filed 23 Jul 2026.